{"disease":{"id":"juvenile-recurrent-respiratory-papillomatosis","name":"juvenile recurrent respiratory papillomatosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06000527","title":"Juvenile Recurrent Respiratory Papillomatosis: Establishment of a French National Cohort (PRR : National Cohort \" REPA \")","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Imagine Institute","has_results":false},{"nct_id":"NCT02859454","title":"Avelumab for People With Recurrent Respiratory Papillomatosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}